There are multiple levers that need to be pulled to allow biosimilars to come to market more broadly in the US, explained Fran Gregory, PharmD, MBA, vice president of emerging therapies, Cardinal Health.
Related Keywords
Nevada ,United States ,Jerrica Mathis ,Travis Tate ,Las Vegas ,Fran Gregory ,Cardinal Health ,Specialty Pharmacy Summit ,Biosimilars ,Cpbm ,Payer ,
comparemela.com © 2020. All Rights Reserved.